Restoril(temazepam) Capsules
DESCRIPTION
Restoril (temazepam) is a benzodiazepine hypnotic agent. The chemical title is 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one, and the structural components is:Restoril™ (temazepam) Structural Formula Illustration
C16H13ClN2O2 two two MW = 300.74
For more info call on 501-732-7051
Temazepam is a white, crystalline substance, very barely soluble in water and sparingly soluble in alcohol USP.
Restoril™ (temazepam) Capsules USP, 7.5 mg, 15 mg, 22.5 mg, and 30 mg, are for oral administration.
7.5 mg, 15 mg, 22.5 mg, and 30 mg Capsules
Active Ingredient: temazepam USP
7.5 mg Capsules
Inactive Ingredients: FD&C Blue #1, FD&C Red #3, gelatin, lactose, magnesium stearate, purple iron oxide, titanium dioxide.
May additionally include: n-butyl alcohol, iron oxide red, shellac, shellac glaze, SD-35A alcohol.
15 mg Capsules
Inactive Ingredients: FD&C Blue #1, FD&C Red #3, gelatin, lactose, magnesium stearate, purple iron oxide, titanium dioxide.
May also include: n-butyl alcohol, FD&C Blue #1/Brilliant Blue FCF Aluminum Lake, iron oxide red, isopropyl alcohol, propylene glycol, shellac, shellac glaze, SD-35A alcohol, SD-45 alcohol.
22.5 mg Capsules
Inactive Ingredients: FD&C Blue #1, FD&C Red #3, gelatin, lactose, magnesium stearate, purple iron oxide, titanium dioxide.
May additionally include: n-butyl alcohol, FD&C Blue #1/Brilliant Blue FCF Aluminum Lake, iron oxide red, isopropyl alcohol, propylene glycol, shellac, shellac glaze, SD-35A alcohol, SD-45 alcohol.
30 mg Capsules
Inactive Ingredients: FD&C Blue #1, FD&C Red #3, gelatin, lactose, magnesium stearate, pink iron oxide, titanium dioxide.
May also include: n-butyl alcohol, FD&C Blue #1/Brilliant Blue FCF Aluminum Lake, iron oxide red, isopropyl alcohol, propylene glycol, shellac, shellac glaze, SD-35A alcohol, SD-45 alcohol.
Indications & Dosage
INDICATIONS
buy Restoril online is indicated for the momentary cure of insomnia (generally 7 to 10 days).
For sufferers with temporary insomnia, guidelines in the prescription must indicate that Restoril™ (temazepam) need to be used for brief periods of time (7 to 10 days).
The medical trials performed in guide of efficacy have been 2 weeks in period with the last formal assessment of sleep latency performed at the cease of treatment.
DOSAGE AND ADMINISTRATION
While the encouraged usual person dose is 15 mg before retiring, 7.5 mg may additionally be sufficient for some patients, and others may additionally want 30 mg. In transient insomnia, a 7.5 mg dose may also be sufficient to enhance sleep latency. In aged or debilitated patients, it is endorsed that remedy be initiated with 7.5 mg till man or woman responses are determined. For more info call on 501-732-7051
